Adults: subcutaneously, 1 ml of 0.01% solution (which is 40 mcg / m2 or 1-2 mcg / kg) is administered at night, once a day, daily for 5-14 days. If necessary, the course of treatment continues for 1 month to 2 ml every third day.
With persistent impairments of immunity, Tactivine is prescribed for 5-14 days for 2 ml daily, and then 2 times a week for 2 ml for 6 months. Repeated courses of treatment are prescribed according to the indicators of immune status.
With multiple sclerosis, the drug is used daily for 1 ml for 5 days, then 2 times a week for 2 ml for life.
In severe cases of multiple sclerosis, Tactivine is prescribed in a complex therapy with glucocorticosteroids (at the stage of application of glucocorticosteroids once a day). Basis preparation is administered in the morning, and Tactivin in the evening time of 1 ml, observing the interval between the administration of glucocorticosteroids and Tactinol 10-12 hours.
For the treatment of surgical patients Tactivine is administered before the operation for 1 ml for 2 days and after it - for 5-14 days.
With malignant tumors, Tactivine is prescribed 5-6-day courses of 1 ml in intervals between courses of basic therapy.
For the treatment of recurrent ophthalmoherpes, 0.1 ml of conjunctival drug is administered, which is 4 μg / m2 or 0.1-0.2 μg / kg / day at intervals of 1 day for 4-5 days, or 1 ml subcutaneously for 7-10 days.
In herpes zoster inject 1 ml of Tactinone daily 7-10 days. The course of treatment can be repeated after 2-3 weeks.
With hepatitis of various etiologies, Tactivine is prescribed for 2-3 ml daily for 10-12 days in combination with the basic preparations. The course of immunocorrection is repeated after 7 days.
For children from 6 months to 14 years, the drug is administered subcutaneously at a rate of 2-3 μg per 1 kg of body weight.
With frequent diseases of acute respiratory-viral diseases, purulent-septic infections, with atopic dermatitis complicated by herpesvirus, Tactivine is administered daily for 7-10 days in combination with the basic preparations. Subsequent administration of the drug for 1 to 2 weeks for 1 injection every other day.
In malignant neoplasms and hepatitis in children, the treatment regimen does not differ from the treatment regimen in adults.
It is recommended to enter in the evening between 17 and 20 hours.